Individuals with Cancer Must Be Included in COVID-19 Vaccine Trials

Individuals with cancer or a history of cancer should be eligible for clinical trials—including COVID-19 vaccine trials—unless there is safety justification for exclusion, the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) assert in a joint position statement released today.

Read the full article here

Related Articles

Health Equity

Watch the ASCO 2023 Annual Meeting Patient Forum Featured Health Equity Article Lung Cancer Screening: Implementation Challenges and Health Equity Considerations for the Western Pacific Region…